Target intelligence / Profile preview

Ovostatin homolog 2

Molecular classification: Other, long non-coding RNA, non-coding RNA

Overview

Ovostatin homolog 2, also referred to by its locus ID LOC728715 and sometimes as ovostatin 1B, is currently annotated as a non-coding RNA (ncRNA) gene in the human genome[3]. No protein product, biological function, or clear disease association has been experimentally established for this locus. There is no evidence it represents a validated molecular target for therapeutic intervention. "Ovostatin 1B" and "OVOS1B" are not recognized as standard gene or protein designations in major nomenclature resources.

Other names: LOC728715ovostatin homolog 2

Beyond the preview

Go deeper on Ovostatin homolog 2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovostatin homolog 2.

Explore the full profile